New Webinar: Acute and longterm neurorecovery after TBI

Traumatic Brain Injury is often called a “silent epidemic” often affecting younger patients with devasting and longlasting complications.

It is therefore great news for the medical community involved in the treatment of TBI patients when significant advances can be reported in clinical research which can improve the longterm recovery results for these patients.

Listen to highly interesting presentations about advances in neuroscience and clinical medicine in TBI care, particularly about the results of the CAPTAIN trial series and follow a panel discussion on modern TBI treatment strategies.

To register for the webinar please go to http://webinars-everpharma.com/

Date: 18.05.2021
Time: 12:00 – 13:30 (MEZ)
Theme: Acute and longterm neurorecovery after TBI
Chair: Pieter Vos

Exosomes mediate the therapeutic benefit of Cerebrolysin® for TBI
Michael Chopp





Advances in acute Neurotrauma treatment
Christian Matula






Long-term neurocognitive consequences of TBI - The CAPTAIN-trials
Peter Lackner






Also experience our webinar-platform, which allows participants to:

  • Life simultaneous translation in Russian
  • English subtitles